Building Research Capacity in Global Tobacco Product Regulation Program

摘要 全球烟草产品监管计划(U18)中的研究能力建设 烟草每年导致全球800多万人死亡，最终导致一半的吸烟者死亡，其中大部分 他们从小就被征召入伍。在美国，48万人的死亡可归因于吸烟 其中包括41 000多人死于二手烟暴露。其毁灭性的影响 由于与烟草使用有关的衰弱疾病，烟草产品的使用也会影响几代人 包括癌症、心脏病和呼吸系统疾病。此外，烟草使用的负面后果是 再加上烟草和相关制造商所采用的战略，他们精心策划了他们的 产品要持续使用。最近，电子烟在全球许多市场的引入已经 进一步复杂化的烟草控制。这些产品缺乏可靠的数据来支持政策制定 这也是一个挑战。因此，规范生产、标签、销售、分销、广告和促销 事实证明，尼古丁和烟草产品的使用在许多情况下特别具有挑战性，甚至对 有强有力的监管措施来解决这些产品，如美国与家庭 《预防吸烟和烟草控制法》(《烟草控制法》)，(P.L.111-31)。 通过这一项目，世卫组织将利用其在国际烟草领域的独特历史、地位、网络和联系 控制和烟草产品监管，以支持食品和药物管理局(FDA)减少 烟草的使用、危害和成瘾。世卫组织在这一领域的经验，包括管理世卫组织研究小组 烟草产品监管、世卫组织烟草实验室网络、其合作中心和 全球烟草监管论坛(GTRF)。此外，其管理和协调 自2015年以来的“全球烟草产品监管研究能力建设计划”，将确保 满足了方案的要求。在吸取经验教训和世卫组织广泛网络的基础上，这项建议 列出了未来五年的几项以科学为基础的活动，以促进和加强研究，以支持 烟草产品监管。其中包括发展和协调#年的多边研究工作。 科学、法律、政策和公共卫生传播。该项目还将扩大数据收集和 信息共享机制、管理和报告协议。精心设计的报告 机制将确保世卫组织监测、评估方案活动、跟踪进展并及时 传播成果。随着FDA的烟草产品中心(CTP)继续行使其授权 限制烟草产品的销售和分销，执行烟草产品标准，审查 申请新烟草产品，并考虑修改风险产品的申请，信息 来自这个项目，包括来自各国的，将使美国能够考虑全球监管和营销 尼古丁和烟草产品的趋势。此外，该项目将促进全球对产品的了解 监管，从而支持世卫组织成员国对尼古丁和烟草产品的有效监管。

Abstract Building Research Capacity in Global Tobacco Product Regulation Program (U18) Tobacco kills over 8 million people globally every year and eventually kills half of its users, the majority of whom are recruited as children. 480,000 of those deaths are attributable to cigarette smoking in the United States, including more than 41,000 deaths resulting from second-hand smoke exposure. The devastating effects of tobacco products also affects generations due to the debilitating diseases associated with tobacco use including cancer, heart, and respiratory illnesses. Further, the negative consequences of tobacco use are compounded by the strategies employed by tobacco and related manufacturers, who carefully engineer their products to sustain use. In recent times, the introduction of electronic cigarettes to many markets globally has further complicated tobacco control. The paucity of reliable data on these products to support policy making is also a challenge. Therefore, regulating the manufacture, labelling, sale, distribution, advertising and promotion of nicotine and tobacco products has proven particularly challenging in many contexts, even for countries that have strong regulatory measures in place to address these products, such as the United States with the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), (P.L. 111-31). Through this project, WHO will use its unique history, position, networks and contacts in international tobacco control and tobacco product regulation to support the Food and Drug Administration (the FDA) in reducing tobacco use, harm, and addiction. WHO's experience in this area, includes managing the WHO Study Group on Tobacco Product Regulation, the WHO Tobacco Laboratory Network, its Collaborating Centres, and the Global Tobacco Regulators Forum (GTRF). Further, its track record of managing and coordinating the “Building Research Capacity in Global Tobacco Product Regulation Program” since 2015, will ensure that the requirements of the program are met. Building on lessons learned and WHO's extensive networks, this proposal sets out several science-based activities over the next five years to advance and strengthen research to support tobacco product regulation. These include development and coordination of multilateral research efforts in science, law, policy, and public health communications. The project will also expand data collection and information sharing mechanisms, management and reporting protocol. Carefully designed reporting mechanisms will ensure that WHO monitors, evaluates program activities, tracks progress, and timely disseminates outcomes. As the FDA's Center for Tobacco Products (CTP) continues to exercise its mandate to place restrictions on the sale and distribution of tobacco products, implement tobacco product standards, review applications for new tobacco products, and consider applications for modified risk products, the information from this project, including from countries, will enable the US to consider global regulatory and marketing trends on nicotine and tobacco products. Further, the project will advance global knowledge on product regulation thereby supporting effective regulation of nicotine and tobacco products in WHO Member States.